Clarksville residents no longer have to travel to big cities to access tomorrow’s medical breakthroughs. Innovative Clinical Research (ICR), a new clinical research organization, has officially opened its doors with one big goal: to bring cutting-edge treatments straight to our community – for free.

ICR connects patients with the latest advancements in medicine through clinical trials, giving them access to promising therapies long before they hit the pharmacy shelves and at no cost to patients.

Innovative Clinical Research at 215 8th St. in Clarksville. (Contributed)
Innovative Clinical Research at 215 8th St. in Clarksville. (Contributed)

A team of trusted local physicians

ICR is led by Dr. Joseph Kosinski and Dr. Bradley Vander Veen, two well-known and highly respected primary care physicians in Clarksville. With more than a decade of clinical research experience, their work has helped bring several major medical breakthroughs to market, including Rezdiffra, Vehozha, the RSV vaccine and Paxlovid.

“Our patients trust us with their care every day, and now we can offer them even more – the chance to access the newest treatments before anyone else,” said Dr. Bradley Vander Veen, co-founder of ICR. “We’re incredibly proud of the work we’ve done to help bring several important medications to market, and we’re just getting started.”

Free access to breakthrough treatments

Clinical research often gives patients early access to the most advanced therapies – at no cost. ICR covers all study-related medical expenses, and many participants are also compensated for their time and travel.

“We believe everyone deserves access to the most advanced medical care, no matter where they live,” said Mary Kosinski, Ph.D., co-founder of Innovative Clinical Research. “Our mission is to make sure patients in Clarksville have the same opportunities as those in big cities, without the long drives or high price tags.”

One of the most exciting upcoming opportunities: GLP-1 studies for weight loss – the same class of medications such as Ozempic, Wegovy and Munjaro making headlines across the country.

“We’re about to launch several GLP-1 studies that will give our patients access to these powerful weight-loss medications completely free,” said Dr. Joseph Kosinski. “These treatments are expensive and often out of reach for many families. Our patients are thrilled to have this opportunity right here in Clarksville.”

Bringing big-city medicine to our community

ICR is the only group in Clarksville currently offering clinical research, closing the gap between community medicine and academic medical centers. By working directly with local physicians, ICR makes it easy for patients to participate in clinical studies close to home – without referrals or travel to distant hospitals.

Dr. Kosinski and Dr. Vander Veen are continuing to run their busy primary care practices while actively leading research efforts. Their goal is to build a network of local providers who can give their patients the same access to groundbreaking care that they are able to provide to their patients.

“Clinical research has allowed me to offer hope and new options to patients who had exhausted traditional treatments,” said Dr. Vander Veen. “It’s incredibly rewarding to see how these studies can change lives, and we’re excited to help other physicians bring these opportunities to their patients too.”

Current and upcoming studies

ICR focuses on a variety of health conditions including fatty liver disease (MASLD/MASH), cirrhosis, weight loss, high triglycerides, metabolic diseases, vaccines, pediatrics and women’s health. The team also offers free FibroScans for all patients interested in evaluating their liver health.

In addition, new studies are constantly being added as medical innovations continue to advance.

How to get involved

Innovative Clinical Research is currently enrolling patients and partnering with primary care providers, specialists, nurse practitioners, and physician assistants across our community.

If you’d like to learn more, schedule a free FibroScan, or find out if you qualify for a clinical trial, visit the ICR website, email information@ICRresearch.com, or call 931-298-0336.